trending Market Intelligence /marketintelligence/en/news-insights/trending/FD8JBoQw-atVD6EtQ4221Q2 content esgSubNav
In This List

Protagonist Therapeutics appoints director

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Protagonist Therapeutics appoints director

Protagonist Therapeutics, Inc. appointed Sarah Noonberg to the board, replacing Julie Grant.

Noonberg is the chief medical officer of Prothena Corp. plc. Grant, who has stepped down from the board, is a partner at Canaan Partners.